Drug and pharmaceutical recalls
754 federal recalls in the last 12 months. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
- 2026-01-21FDA-DrugAdvanced Pharmaceutical Technology, Inc.Class IIStop using TESTO-100 testosterone pellets
Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.
- 2026-01-21FDA-DrugSUN PHARMACEUTICAL INDUSTRIES INCClass IIIStop using Sun Pharmaceutical clindamycin solution
Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
- 2026-01-21FDA-DrugSUN PHARMACEUTICAL INDUSTRIES INCClass IIIStop using recalled fluocinolone acetonide solution
Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D.
- 2026-01-14FDA-DrugAvKAREClass IIStop using AvKARE Rosuvastatin 10 mg tablets
Out of specification for dissolution.
- 2026-01-14FDA-DrugMedinatura New Mexico, inc.Class IStop using ClearLife Allergy Nasal Spray
Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.
- 2026-01-14FDA-DrugMedinatura New Mexico, inc.Class IStop using MediNatura ReBoost Nasal Spray
Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.
- 2026-01-14FDA-DrugSpecGx, LLCClass IICheck your SpecGx pain medication bottle
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
- 2026-01-14FDA-DrugSpecGx, LLCClass IICheck your SpecGx oxycodone tablets
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
- 2026-01-14FDA-DrugSignature Formulations, LLCClass IIStop using ORL Kids Natural Toothpaste
cGMP Deviations
- 2026-01-14FDA-DrugSignature Formulations, LLCClass IIStop using ORL Kids Mouthwash Bubblegum
cGMP Deviations
- 2026-01-14FDA-DrugImprimis NJOF, LLCClass IIStop using Imprimis Tri-Moxi eye injections
Presence of particulate matter - Glass like particles.
- 2026-01-14FDA-DrugImprimis NJOF, LLCClass IIStop using Imprimis NJOF eye injection
Presence of particulate matter - Glass like particles.
- 2026-01-14FDA-DrugImprimis NJOF, LLCClass IIStop using Imprimis eye injection immediately
Presence of particulate matter - Glass like particles.
- 2026-01-14FDA-DrugAlembic Pharmaceuticals LimitedClass IIIStop using Alembic Fesoterodine Fumarate tablets
Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
- 2026-01-07FDA-DrugZydus Pharmaceuticals (USA) IncClass IIICheck your trazodone tablets for dents
Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.
- 2026-01-07FDA-DrugGlenmark Pharmaceuticals Inc., USAClass IIStop using Glenmark Ondansetron 4mg tablets
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
- 2026-01-07FDA-DrugNovo Nordisk Inc.Class IIStop using Novo Nordisk Wegovy injection pens
Presence of Particulate Matter: Hair was found in a prefilled syringe
- 2026-01-07FDA-DrugNovo Nordisk Inc.Class IIStop using Wegovy 0.5 mg prefilled pens (specific lots)
Presence of Particulate Matter: Hair was found in a prefilled syringe
- 2026-01-07FDA-DrugCareFusion 213, LLCClass IIStop using BD ChloraPrep Triple Swabsticks
Lack of Assurance of Sterlity
- 2025-12-31FDA-DrugMerck Sharp & Dohme LLCClass IIStop using Merck Noxafil Powdermix immediately
Presence of particulate matter: potential presence of metal particulates in the product.
- 2025-12-31FDA-DrugMerck Sharp & Dohme LLCClass IIStop using Merck Emend suspension lot Z014503
Presence of particulate matter: potential presence of metal particulates in the product.
- 2025-12-24FDA-DrugSUN PHARMA /TAROClass IIStop using Taro Ciclopirox Shampoo 1%
Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint
- 2025-12-24FDA-DrugPreferred Pharmaceuticals, Inc.Class IIStop using Preferred Pharmaceuticals ondansetron ODT
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
- 2025-12-24FDA-DrugSOMERSET THERAPEUTICS LLCClass IIIStop using Somerset Therapeutics cisatracurium besylate
Subpotent product:out of specification assay results observed during long term stability testing.
- 2025-12-24FDA-DrugSOMERSET THERAPEUTICS LLCClass IIIStop using Somerset cisatracurium besylate injection
Subpotent product:out of specification assay results observed during long term stability testing.
- 2025-12-24FDA-DrugSOMERSET THERAPEUTICS LLCClass IIICheck cisatracurium besylate vials for affected lots
Subpotent product:out of specification assay results observed during long term stability testing.
- 2025-12-24FDA-DrugGolden State Medical Supply Inc.Class IIStop using Golden State Medical Supply baclofen
Presence of Foreign Tablets/Capsules
- 2025-12-24FDA-DrugNovocol Pharmaceutical of Canada, Inc.Class IIStop using OraVerse injection cartridges
Defective container: cracked/broken cartridges
- 2025-12-24FDA-DrugNovocol Pharmaceutical of Canada, Inc.Class IIStop using Novocol Carbocaine 3% injection
Defective container: cracked/broken cartridges
- 2025-12-24FDA-DrugNovocol Pharmaceutical of Canada, Inc.Class IIStop using Novocol Mepivacaine HCI injection
Defective container: cracked/broken cartridges
Get notified about new drug recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.
Get the Sunday Brief